# Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.

> **NCT02770729** · PHASE3 · TERMINATED · sponsor: **University of Campinas, Brazil** · enrollment: 3640 (actual)

## Conditions studied

- Endophthalmitis

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** No injection of moxifloxacin

## Key facts

- **NCT ID:** NCT02770729
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2018-02
- **Final completion:** 2018-05-07
- **Target enrollment:** 3640 (ACTUAL)
- **Last updated:** 2018-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02770729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02770729, "Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02770729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*